Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-14 Exercise | 2024-02-16 4:00 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | George Jean Director | 14,150 | $1.69 | 2,458,415 (Direct) | View |
| 2024-02-14 Exercise | 2024-02-16 4:00 pm | 2024-02-03 2033-02-03 | Cyteir Therapeutics Inc. | CYT | George Jean Director | 14,150 | $0 | 2,458,415 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 4:42 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | George Jean Director | 14,150 | $0 | 14,150 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 4:59 pm | N/A 2032-02-22 | Cyteir Therapeutics Inc. | CYT | George Jean Director | 14,150 | $0 | 14,150 (Direct) | View |
| 2021-06-22 Conversion | 2021-06-24 8:48 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | George Jean Director | 10,776,294 | $0 | 2,444,268 (Indirect) | View |
Ownership | 2021-06-17 9:31 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | George Jean Director | 0 | $0 | 2,461,515 (Indirect) | View |
| 2021-06-11 Option Award | 2021-06-14 4:05 pm | N/A 2031-06-10 | Calithera Biosciences Inc. | CALA | George Jean Director | 20,000 | $0 | 20,000 (Direct) | View |
Ownership | 2021-02-16 5:23 pm | N/A N/A | Gemini Therapeutics Inc. | GMTX | George Jean Director 10% Owner | 0 | $0 | 4,836,106 (Indirect) | View |
| 2020-07-21 Conversion | 2020-07-22 4:18 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | LSV Associates LLC Lightstone Ventures L.P. Lightstone Ventures (A) L.P. Lightstone Ventures II L.P. Lightstone Ventures II (A) L.P. LSV Associates II LLC Carusi Michael A George Jean Plain Henry A JR 10% Owner | 7,360,342 | $0 | 120,212 (Indirect) | View |
Ownership(A) | 2020-07-22 4:15 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | LSV Associates LLC Lightstone Ventures L.P. Lightstone Ventures (A) L.P. Lightstone Ventures II L.P. Lightstone Ventures II (A) L.P. LSV Associates II LLC Carusi Michael A George Jean Plain Henry A JR 10% Owner | 0 | $0 | 3,669,171 (Indirect) | View |
Ownership | 2020-07-16 8:45 pm | N/A N/A | ALX ONCOLOGY HOLDINGS INC | ALXO | LSV Associates LLC Lightstone Ventures L.P. Lightstone Ventures (A) L.P. Lightstone Ventures II L.P. Lightstone Ventures II (A) L.P. LSV Associates II LLC Carusi Michael A George Jean 10% Owner | 0 | $0 | 3,669,171 (Indirect) | View |
| 2020-06-09 Option Award | 2020-06-11 4:02 pm | N/A 2030-06-08 | Calithera Biosciences Inc. | CALA | George Jean Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-01-22 Option Award | 2020-01-24 5:41 pm | N/A 2030-01-22 | ACCELERON PHARMA INC | XLRN | George Jean Director | 9,562 | $0 | 13,312 (Direct) | View |